Wendy V. Norman

ORCID: 0000-0003-4340-7882
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Health and Contraception
  • Maternal and Perinatal Health Interventions
  • Reproductive Health and Technologies
  • Maternal and fetal healthcare
  • Global Maternal and Child Health
  • Ectopic Pregnancy Diagnosis and Management
  • Adolescent Sexual and Reproductive Health
  • Assisted Reproductive Technology and Twin Pregnancy
  • Mobile Health and mHealth Applications
  • Autopsy Techniques and Outcomes
  • Primary Care and Health Outcomes
  • Maternal Mental Health During Pregnancy and Postpartum
  • Homicide, Infanticide, and Child Abuse
  • Congenital Heart Disease Studies
  • Health Policy Implementation Science
  • Prenatal Substance Exposure Effects
  • Forensic Anthropology and Bioarchaeology Studies
  • Reproductive tract infections research
  • Fetal and Pediatric Neurological Disorders
  • Pregnancy and Medication Impact
  • Child and Adolescent Health
  • Meta-analysis and systematic reviews
  • Healthcare Policy and Management
  • Advanced MRI Techniques and Applications
  • Opioid Use Disorder Treatment

Faculty of Public Health
2019-2025

London School of Hygiene & Tropical Medicine
2019-2025

University of British Columbia
2016-2025

Monash University
2025

BC Centre for Disease Control
2024

Decatur Memorial Hospital
2024

Alabama College of Osteopathic Medicine
2024

Universidad Nacional Pedro Henríquez Ureña
2024

Society for Public Health Education
2022-2024

Women's Health Research Institute
2011-2023

<h3>Importance</h3> Interpregnancy intervals shorter than 18 months are associated with higher risks of adverse pregnancy outcomes. It is currently unknown whether short increased among older women to the same extent as younger women. <h3>Objective</h3> To evaluate association between interpregnancy (delivery conception) interval and outcomes modified by maternal age. <h3>Design, Setting, Participants</h3> A population-based cohort study conducted in British Columbia, Canada, evaluated 2 or...

10.1001/jamainternmed.2018.4696 article EN JAMA Internal Medicine 2018-11-01

No area of healthcare is immune to the impact COVID-19. The pandemic will affect sexual and reproductive health (SRH) worldwide in positive negative ways. Home isolation fears contracting virus appear have led decreased uptake SRH services, increased reports intimate partner violence, some settings reduced access contraception safe abortion care.1 2 Vulnerable populations are disproportionately affected, including young people, Indigenous peoples, as well refugees asylum-seekers whose safety...

10.1136/bmjsrh-2020-200709 article EN other-oa BMJ Sexual & Reproductive Health 2020-08-11

Although abortion was completely decriminalized in Canada 36 years ago, barriers to pregnancy prevention and termination persist across the country, such as travel information gaps. Research demonstrates incarcerated people face family planning care, yet there is no systematic data collection of sexual reproductive health experiences outcomes among Canada. The aim this study explore care women gender diverse who have experienced incarceration We conducted a qualitative community-based...

10.1186/s12905-024-03523-z article EN cc-by-nc-nd BMC Women s Health 2025-01-23

Although mifepristone for medication abortion has been available in Canada since a regulatory change 2017, leading to its rapid uptake, the effects of this availability on regional access are unknown. We sought examine how community pharmacy dispensation affected distribution services over time Ontario, Canada. used linked health administrative data identify cohort all and procedural abortions provided Ontario from 2017 2022, defined by outpatient dispensations billing, diagnostic, procedure...

10.1503/cmaj.241505 article EN cc-by-nc-nd Canadian Medical Association Journal 2025-04-06

In the United States, mifepristone is available for medical abortion (for use with misoprostol) only Risk Evaluation and Mitigation Strategy (REMS) restrictions, despite an absence of evidence to support such restrictions. Mifepristone has been in Canada a normal prescription since November 2017.

10.1056/nejmsa2109779 article EN New England Journal of Medicine 2021-12-08

To compare the diagnostic accuracy of post-mortem magnetic resonance imaging (PMMR) specifically for non-cardiac thoracic pathology in fetuses and children, compared with conventional autopsy.Institutional ethics approval parental consent was obtained. A total 400 unselected children underwent PMMR before autopsy, reported blinded to other dataset.Of abnormalities, 113 (28 %) were found at autopsy. Overall sensitivity specificity (95 % confidence interval) any poor 39.6 (31.0, 48.9) 85.5...

10.1007/s00330-014-3313-8 article EN cc-by-nc European Radiology 2014-08-30

Rural induced abortion service has declined in Canada. Factors influencing provision by rural physicians are unknown. This study assessed distribution, practice, and experiences among compared to urban providers the Canadian province of British Columbia (BC).We used mixed methods assess on BC registry providers. In 2011 we distributed a previously-published questionnaire conducted semi-structured interviews.Surveys were returned 39/46 (85%) Half family physicians, within both cohorts....

10.1371/journal.pone.0067023 article EN cc-by PLoS ONE 2013-06-28

Access to family planning health services in Canada has been historically inadequate and inequitable. A potential solution appeared when Health approved mifepristone, the gold standard for medical abortion, July 2015. We sought investigate factors that influence successful initiation ongoing provision of abortion among Canadian professionals how these relate policies, systems, service access throughout Canada.We conducted 1-on-1 semistructured interviews with a national sample...

10.1370/afm.2562 article EN The Annals of Family Medicine 2020-09-01

Contraceptives are underutilized in Canada, and nearly one three Canadian women will have an abortion her lifetime. To help delineate a national family planning research agenda, the authors interviewed healthcare providers organizational stakeholders to explore their perspective on barriers contraception across regions of Canada.Semi-structured interviews were conducted based validated frameworks for assessing access quality. The purposefully selected 14 key from government agencies,...

10.12927/hcpol.2015.24169 article EN Healthcare policy 2015-02-25

Physician-scientists are individuals who actively participate in patient care, have undergone additional research training, and devote the majority of their time to research. traditionally primary catalysts bridging translational gap-that is, failure link fundamental new knowledge pathobiology disease with advances health care policy a timely manner. However, there has been shift away from training physician-scientists, financial support for physician-scientist is diminishing globally,...

10.1097/acm.0000000000001857 article EN Academic Medicine 2017-08-16
Coming Soon ...